UK markets close in 3 hours 17 minutes
  • FTSE 100

    7,395.36
    -98.77 (-1.32%)
     
  • FTSE 250

    21,687.86
    -575.38 (-2.58%)
     
  • AIM

    1,092.69
    -39.39 (-3.48%)
     
  • GBP/EUR

    1.1933
    -0.0014 (-0.12%)
     
  • GBP/USD

    1.3489
    -0.0056 (-0.41%)
     
  • BTC-GBP

    24,816.20
    -1,816.88 (-6.82%)
     
  • CMC Crypto 200

    760.32
    +517.64 (+213.30%)
     
  • S&P 500

    4,397.94
    -84.79 (-1.89%)
     
  • DOW

    34,265.37
    -450.03 (-1.30%)
     
  • CRUDE OIL

    84.87
    -0.27 (-0.32%)
     
  • GOLD FUTURES

    1,840.60
    +8.80 (+0.48%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • HANG SENG

    24,656.46
    -309.09 (-1.24%)
     
  • DAX

    15,283.12
    -320.76 (-2.06%)
     
  • CAC 40

    6,919.55
    -149.04 (-2.11%)
     

Global Intravenous (IV) Solutions Market to Reach US$15 Billion by the Year 2026

·24-min read

Abstract: Global Intravenous (IV) Solutions Market to Reach US$15 Billion by the Year 2026 Intravenous solutions are nutrients such as amino acids, vitamins & minerals, carbohydrates, and parenteral lipid emulsion among others, which are delivered intravenously to the patient.

New York, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Intravenous (IV) Solutions Industry" - https://www.reportlinker.com/p06031988/?utm_source=GNW
Intravenous feeding of nutrients involves administration of nutritional supplements to the body through vein. Intravenous therapy is generally administered to patients with a non-functional gastrointestinal tract or those unable to consume nutrition through the oral route. An aging population, rising prevalence of chronic diseases, and the need to address nutritional needs of such patients are fueling growth in IV solutions market. Since the geriatric population is more likely to experience deficiency of various essential nutrients, intravenous therapy is often used to provide the necessary nutrition in this population. Growing number of preterm births is another factor driving market growth. Increasing number of pediatric GI disorders is also likely to foster demand for infant IV nutrition going forward. Another factor fueling growth in the IV solutions market is the growing threat of malnutrition particularly in low
and mid-income nations. The market is anticipated to generate increased revenue due to the IV infusions` rising positive clinical trials, which are propelling the vitamin C IV therapy`s adoption to treat cancer.

Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$15 Billion by 2026, growing at a CAGR of 6.8% over the analysis period. Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to grow at a 7.1% CAGR to reach US$11 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period. This segment currently accounts for a 32.8% share of the global Intravenous (IV) Solutions market. Total parenteral nutrition (TPN) is an approach that involves intravenous infusion of carefully balanced blend of minerals and vitamins. The treatment is administered in life-threatening scenarios such as intestinal failure, where a patient is unable to digest and absorb essential nutrients including minerals and vitamins required for survival. Furthermore, the TPN market is estimated to develop rapidly because of the increased significance in treating inflammatory bowel diseases such as Crohn`s and ulcerative colitis disease. Peripheral Parenteral Nutrition (PPN) is a short-term therapy that is provided only until enteral or central venous access is obtained or in the form of supplement to oral intake.

The U.S. Market is Estimated at $4.1 Billion in 2021, While China is Forecast to Reach $1.4 Billion by 2026

The Intravenous (IV) Solutions market in the U.S. is estimated at US$4.1 Billion in the year 2021. The country currently accounts for a 38.86% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$684.3 Million by the end of the analysis period. A growing elderly population with greater susceptibility to chronic illnesses is driving need for IV solutions in developed economies. Advent of novel IV solutions to meet the nutritional needs of pediatric patients, and growing awareness about the benefits of IV nutrition therapy for patients suffering from severe malnutrition are presenting favorable growth opportunities in developed economies. The high prevalence of malnourishment among children and high instances of malnutrition among expectant mothers, due to the large number of low
and mid-income nations in the regions, are driving demand for IV solutions. To deal with the issue, global organizations such as the UN and regional governments are undertaking aggressive awareness programs to reduce mortality rates, which is encouraging greater adoption of IV and PN solutions in healthcare settings.


Select Competitors (Total 67 Featured)

  • Ajinomoto

  • Anhui Medipharm Co. Ltd

  • B. Braun Melsungen AG

  • Baxter International

  • Fresenius Kabi AG

  • Grifols

  • ICU Medical Inc.

  • Omnicare

  • Vifor Pharma

  • Wuhan Uni-Pharma Bio-Tech Co. Ltd




Read the full report: https://www.reportlinker.com/p06031988/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021?
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Pandemic Affects Demand for Intravenous Solutions
Elective Surgeries Report Roller-Coaster Ride Amid COVID-19,
Affecting Demand for IV Solutions
EXHIBIT 2: COVID-19 Induced YOY Decline in Heart Surgery
Volumes in the US in 2020
COVID-19 Results in Colossal Backlog of Elective Surgeries &
Extended Waiting Times
An Introduction to Intravenous (IV) Solutions
Types of Intravenous Solutions
Global Market Prospects & Outlook
TPN Emerges as the Largest Segment in the IV Solutions Market
Single Dose Amino Acid Solutions: The Major Nutrient Type
Developed Economies Lead, Developing Regions to Propel Future
Growth
Competition
World Brands
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Growing Prevalence of Malnutrition in Hospitalized Patients to
Fuel Need for IV Solutions
EXHIBIT 3: Daily Requirements for Adults (Male and Female) by
Nutrient Type
EXHIBIT 4: Energy Requirements by Age and Gender
Rising Prevalence of Chronic Diseases and Resultant Need for
Additional Nutrition Enhances Need to Administer IV Solutions
Rising Cancer Incidence and Need for Nutritional Support
EXHIBIT 5: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 6: Global Number of New Cancer Cases and Cancer-related
Deaths by Cancer Site for 2020
EXHIBIT 7: Number of New Cancer Cases and Deaths (in Million)
by Region for 2020
Alarming Rise in Diabetes Incidence Worldwide
EXHIBIT 8: World Diabetes and Population Statistics (2019, 2030 &
2045)
EXHIBIT 9: World Diabetes Prevalence (2000-2045)
EXHIBIT 10: Global Prevalence of Diabetes: Number of Adults
Diagnosed with Diabetes (in Million) by Gender for 2019, 2030
and 2045
EXHIBIT 11: Global Diabetes Mellitus Population Breakdown by
Geographic Region: 2019, 2030 and 2045
Unrelenting Threat of HIV/AIDS Infection
EXHIBIT 12: Global HIV Prevalence: Number of People Living with
AIDs (in Thousands) by Region for 2020
EXHIBIT 13: Number of AIDS-Related Deaths (in Thousands) by
Region for 2018
Nutritional Management of Patients with Neurological Diseases
EXHIBIT 14: Burden of Neurological Diseases: Deaths Per 100,000
Population due to Neurological Conditions in Select Countries
Concerns over Fluid Depletion from Body Due to GI & Diarrheal
Diseases Necessitate IV Fluid Administration
Growing Numbers of Pre-term Births Drives Demand for IV Solutions
EXHIBIT 15: Top Countries Ranked by Most Number of Preterm Births
EXHIBIT 16: Countries with Highest Preterm Birth Rates: Number
of Preterm Births Per 100 Live Births by Top Countries
Demand Rises for Home Intravenous Nutritional Therapies
Premixed IV Nutrition: A Step towards Safer Medication Practices
Premixed Formulations Present Efficient Delivery System
Iron Replacement Therapies: Potential for Growth
Growing Demand for Low-Cost Intravenous Nutrition Solutions
COVID-19 Outbreak: Combating Medication Errors in IV Infusion
Aging Global Demography and Resultant Rise in Need for
Nutrition Management Augurs Well for the Market
EXHIBIT 17: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 18: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Increasing Healthcare Expenditure Creates Conducive Environment
EXHIBIT 19: World Healthcare Expenditure (In US$ Trillion) for
the Years for 2017, 2019, 2021 & 2023
Challenges Confronting IV Solutions Market

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Intravenous (IV)
Solutions by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Intravenous (IV) Solutions
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Intravenous (IV)
Solutions by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027

Table 4: World Current & Future Analysis for Total Parenteral
Nutrition by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Total Parenteral Nutrition
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Total Parenteral
Nutrition by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 7: World Current & Future Analysis for Peripheral
Parenteral Nutrition by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Peripheral Parenteral
Nutrition by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Peripheral Parenteral
Nutrition by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 10: World Current & Future Analysis for Single Dose Amino
Acids by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Single Dose Amino Acids by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Single Dose Amino Acids
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Current & Future Analysis for Vitamins &
Minerals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Vitamins & Minerals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Vitamins & Minerals by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Current & Future Analysis for Carbohydrates by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Carbohydrates by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Carbohydrates by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Current & Future Analysis for Parenteral Lipid
Emulsion by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Parenteral Lipid Emulsion
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Parenteral Lipid
Emulsion by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 22: World Current & Future Analysis for Other Nutrients
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Other Nutrients by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other Nutrients by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Intravenous (IV) Solutions by
Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 28: USA Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Intravenous (IV) Solutions by
Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

CANADA
Table 31: Canada Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 34: Canada Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

JAPAN
Table 37: Japan Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 40: Japan Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

CHINA
Table 43: China Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 46: China Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

EUROPE
Table 49: Europe Current & Future Analysis for Intravenous (IV)
Solutions by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 50: Europe Historic Review for Intravenous (IV) Solutions
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 51: Europe 15-Year Perspective for Intravenous (IV)
Solutions by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2021 & 2027

Table 52: Europe Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 55: Europe Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

FRANCE
Table 58: France Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 61: France Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

GERMANY
Table 64: Germany Current & Future Analysis for Intravenous
(IV) Solutions by Type - Total Parenteral Nutrition and
Peripheral Parenteral Nutrition - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: Germany Historic Review for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 67: Germany Current & Future Analysis for Intravenous
(IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

ITALY
Table 70: Italy Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 73: Italy Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

UNITED KINGDOM
Table 76: UK Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Intravenous (IV) Solutions by
Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Intravenous (IV) Solutions
by Type - Percentage Breakdown of Value Sales for Total
Parenteral Nutrition and Peripheral Parenteral Nutrition for
the Years 2012, 2021 & 2027

Table 79: UK Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Intravenous (IV) Solutions by
Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Intravenous (IV) Solutions
by Nutrient - Percentage Breakdown of Value Sales for Single
Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

SPAIN
Table 82: Spain Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 83: Spain Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 84: Spain 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 85: Spain Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: Spain Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,
Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 87: Spain 15-Year Perspective for Intravenous (IV)
Solutions by Nutrient - Percentage Breakdown of Value Sales for
Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates,
Parenteral Lipid Emulsion and Other Nutrients for the Years
2012, 2021 & 2027

RUSSIA
Table 88: Russia Current & Future Analysis for Intravenous (IV)
Solutions by Type - Total Parenteral Nutrition and Peripheral
Parenteral Nutrition - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Russia Historic Review for Intravenous (IV) Solutions
by Type - Total Parenteral Nutrition and Peripheral Parenteral
Nutrition Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 90: Russia 15-Year Perspective for Intravenous (IV)
Solutions by Type - Percentage Breakdown of Value Sales for
Total Parenteral Nutrition and Peripheral Parenteral Nutrition
for the Years 2012, 2021 & 2027

Table 91: Russia Current & Future Analysis for Intravenous (IV)
Solutions by Nutrient - Single Dose Amino Acids, Vitamins &
Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other
Nutrients - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 92: Russia Historic Review for Intravenous (IV) Solutions
by Nutrient - Single Dose Amino Acids, Vitamins & Minerals,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06031988/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting